syn-3-(1-(1H-imidazol-2-yl)-2-methylpropyl)-6-(8-fluoronaphthalen-2-yl)pyridin-2(1H)-one

ID: ALA4740657

PubChem CID: 137487264

Max Phase: Preclinical

Molecular Formula: C23H21FN2O4

Molecular Weight: 408.43

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)[C@H](C[C@@H]1OC(=O)NC1=O)c1ccc(-c2ccc3cccc(F)c3c2)[nH]c1=O

Standard InChI:  InChI=1S/C23H21FN2O4/c1-12(2)16(11-20-22(28)26-23(29)30-20)15-8-9-19(25-21(15)27)14-7-6-13-4-3-5-18(24)17(13)10-14/h3-10,12,16,20H,11H2,1-2H3,(H,25,27)(H,26,28,29)/t16-,20-/m0/s1

Standard InChI Key:  APGRDJVFQHCAOP-JXFKEZNVSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   37.9161  -20.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9161  -21.3994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6215  -21.8059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.3269  -21.3994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3269  -20.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6215  -20.1715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2061  -20.1788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2079  -21.8095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.0323  -21.8079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0326  -22.6268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7396  -23.0368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7369  -21.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4447  -21.8061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4428  -22.6287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1540  -23.0389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8635  -22.6282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8594  -21.8050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1515  -21.3963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5005  -20.5893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7921  -20.1868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5075  -21.4065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.1480  -20.5791    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   37.2020  -19.3555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4889  -18.9540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7444  -19.2865    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.1946  -18.6814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6002  -17.9723    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4002  -18.1352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0012  -17.5855    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3809  -18.7736    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  1  1  0
  2  8  2  0
  9 10  2  0
 10 11  1  0
 11 14  2  0
 13 12  2  0
 12  9  1  0
  4  9  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  7 19  1  6
 19 20  1  0
 19 21  1  0
 18 22  1  0
  7 23  1  0
 24 23  1  6
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 24 28  1  0
 28 29  2  0
 26 30  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4740657

    ---

Associated Targets(Human)

PTGER3 Tclin Prostanoid EP3 receptor (1985 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.43Molecular Weight (Monoisotopic): 408.1485AlogP: 4.10#Rotatable Bonds: 5
Polar Surface Area: 88.26Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 6.64CX Basic pKa: CX LogP: 3.32CX LogD: 2.52
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.67Np Likeness Score: -0.41

References

1. Zhang X,Zhu B,Guo L,Bakaj I,Rankin M,Ho G,Kauffman J,Lee SP,Norquay L,Macielag MJ.  (2021)  Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes.,  12  (3): [PMID:33738072] [10.1021/acsmedchemlett.0c00667]

Source